We observed a reduction in tumor size in the group of mice receiving Akt2-OE CTLs, but no significant change was seen in the groups receiving control or Akt1-OE CTLs (figure 2B,C and online supplemental figure S4). This evidence concerns the gene AKT1 and neoplasm.